Psychometric validation of the 1-month recall Uterine Fibroid Symptom and Health-Related Quality of Life questionnaire (UFS-QOL)

Journal of Patient-Reported Outcomes

Table 3 Relationship (Spearman’s correlations) of UFS-QOL scale scores with bleeding diary assessments in VENUS I and VENUS II and PGI-I in VENUS II after 12 weeks of treatment; per protocol population (patient-reported outcome approach)

All p < 0.0001
^aNumber of days in previous 35 days – “bleeding”: days with rating of “bleeding” and “heavy bleeding”
^b“Heavy bleeding”: days with rating of “heavy bleeding”. HRQoL health-related quality of life; PGI-I Patient Global Impression of Improvement scale; UFS-QOL Uterine Fibroid Symptom and Health-Related Quality of Life questionnaire